16-50153020-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001040284.3(TENT4B):c.68C>T(p.Ser23Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000396 in 1,515,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001040284.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TENT4B | NM_001040284.3 | c.68C>T | p.Ser23Phe | missense_variant | Exon 1 of 13 | NP_001035374.2 | ||
TENT4B | NM_001040285.3 | c.68C>T | p.Ser23Phe | missense_variant | Exon 1 of 13 | NP_001035375.2 | ||
TENT4B | XM_011523275.4 | c.68C>T | p.Ser23Phe | missense_variant | Exon 1 of 13 | XP_011521577.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151020Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000177 AC: 2AN: 113306Hom.: 0 AF XY: 0.0000320 AC XY: 2AN XY: 62436
GnomAD4 exome AF: 0.00000293 AC: 4AN: 1364438Hom.: 0 Cov.: 31 AF XY: 0.00000297 AC XY: 2AN XY: 673406
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151140Hom.: 0 Cov.: 28 AF XY: 0.0000135 AC XY: 1AN XY: 73890
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.68C>T (p.S23F) alteration is located in exon 1 (coding exon 1) of the PAPD5 gene. This alteration results from a C to T substitution at nucleotide position 68, causing the serine (S) at amino acid position 23 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at